The U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation have launched Phase 2 of the LymeX Diagnostics Prize, inviting the 10 Phase 1 winners to participate in a virtual accelerator.
Through September 2023, the accelerator cohort will refine their concepts for detecting active Lyme disease infections in people. The goal of the multiphase LymeX Innovation Accelerator (LymeX) competition is to nurture the development of diagnostics toward Food and Drug Administration review.
“Phase 1 of the LymeX Diagnostics Prize recognized ten winners for their substantial potential to transform the future of Lyme disease diagnostics,” according to Rear Admiral Michael Iademarco, Deputy Assistant Secretary for the Office of the Science and Medicine in the HHS Office of the Assistant Secretary for Health.
Read more at: https://www.lymedisease.org/lymex-advances-phase-2/
